Low-dose rasburicase in hematologic malignancies.

about

Acute leukemia in children: A review of the current Indian data Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome

P2860

Q28066885-0E3951FE-B219-46C1-B5F2-0B445D96ABFC Q38371659-4507580E-B81F-441A-8CAF-643EFC328719 Q58125072-789AC008-0EAC-4483-B1E1-D5F96F77796C

P2860

Low-dose rasburicase in hematologic malignancies.

Item

http://www.wikidata.org/entity/Q51105458

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Low-dose rasburicase in hematologic malignancies.

@en

Low-dose rasburicase in hematologic malignancies.

@nl

type

Item

label

Low-dose rasburicase in hematologic malignancies.

@en

Low-dose rasburicase in hematologic malignancies.

@nl

prefLabel

Low-dose rasburicase in hematologic malignancies.

@en

Low-dose rasburicase in hematologic malignancies.

@nl

P1476

Low-dose rasburicase in hematologic malignancies.

@en

P2093

Krishnakumar Rathnam

http://www.w3.org/2001/XMLSchema#string

Priya Rajan

http://www.w3.org/2001/XMLSchema#string

Rajeswari Dhanabalan

http://www.w3.org/2001/XMLSchema#string

Somasundaram Jayabose

http://www.w3.org/2001/XMLSchema#string

T Kasi Viswanathan

http://www.w3.org/2001/XMLSchema#string

Vignesh Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer

The tumor lysis syndrome

Complications of "very high" leukocytosis in pediatric acute leukemia patients managed without rasburicase and leukopheresis.

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.

Tumour lysis syndrome: new therapeutic strategies and classification.

Onco-nephrology: tumor lysis syndrome.

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.

Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.

Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.

Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.

P2888

s12098-014-1606-1

P304

458-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-014-1606-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25338496

http://www.w3.org/2001/XMLSchema#string

Low-dose rasburicase in hematologic malignancies.

about

P2860

P2860

Low-dose rasburicase in hematologic malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698